Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -36.45%2.07B | -23.31%3.06B | -13.09%3.28B | -0.69%3.46B | 7.42%3.26B | 24.41%4B | 13.01%3.77B | 12.24%3.48B | -2.72%3.03B | -9.18%3.21B |
| Transactional financial assets | -1.78%125.94M | -5.87%122.63M | -24.26%123.43M | -35.48%125.43M | -14.87%128.22M | -22.79%130.28M | -18.33%162.97M | -10.70%194.41M | 43.44%150.62M | 40.59%168.74M |
| Notes receivable and accounts receivable | -10.71%16.11B | -10.69%15.96B | -12.25%16.4B | -12.16%16.22B | -15.61%18.05B | -16.15%17.87B | -10.85%18.69B | -8.06%18.47B | 4.51%21.38B | 4.93%21.31B |
| -Notes receivable | -11.35%1.04B | -25.99%810.85M | -22.04%1.04B | -18.79%900.43M | -15.26%1.18B | -19.89%1.1B | 5.91%1.33B | -12.78%1.11B | -6.51%1.39B | -13.49%1.37B |
| -Accounts receivable | -10.66%15.07B | -9.69%15.15B | -11.50%15.37B | -11.74%15.32B | -15.63%16.87B | -15.90%16.77B | -11.92%17.36B | -7.74%17.36B | 5.37%19.99B | 6.49%19.94B |
| Other receivables (including interest and dividends) | 22.93%2.36B | -3.68%1.78B | -5.38%1.83B | -5.24%1.82B | -2.15%1.92B | -3.80%1.84B | -1.93%1.94B | -0.45%1.92B | -8.01%1.96B | -6.17%1.92B |
| -Dividend receivable | 250.28%5.61M | 437.48%8.61M | 68.81%8.61M | 68.81%8.61M | 0.00%1.6M | 0.00%1.6M | 218.40%5.1M | 218.40%5.1M | --1.6M | --1.6M |
| -Other receivable | ---- | -4.06%1.77B | ---- | ---- | ---- | -3.80%1.84B | ---- | -0.63%1.92B | ---- | -6.25%1.91B |
| Advance payment | -44.18%294.93M | -24.13%350.38M | -29.60%359.87M | -30.56%317.29M | -21.70%528.39M | -34.11%461.84M | -37.73%511.21M | -64.00%456.91M | -21.87%674.83M | -16.08%700.89M |
| Inventories | -7.36%3.33B | -4.00%3.36B | -3.02%3.36B | -5.23%3.49B | 3.47%3.59B | -5.38%3.5B | -14.63%3.47B | -12.25%3.68B | -4.72%3.47B | 9.84%3.7B |
| Receivable financing | -24.76%75.39M | -49.31%59.13M | 12.34%137.88M | -0.98%164.79M | -43.87%100.2M | -10.83%116.67M | -30.28%122.74M | 17.66%166.42M | 9.14%178.51M | -13.24%130.84M |
| Non-current assets due within one year | ---- | -98.58%2.16M | -88.00%23.21M | -89.69%23.69M | -61.87%86M | -43.40%152.25M | -47.96%193.49M | -40.83%229.86M | 1,371.42%225.57M | 5,738.04%269M |
| Other current assets | 11.49%213.31M | 31.69%245.51M | 11.01%240.32M | 2.37%217.58M | -44.42%191.33M | -46.90%186.43M | 49.48%216.48M | 7.76%212.54M | -8.98%344.23M | -10.82%351.09M |
| Total current assets | -11.74%24.58B | -11.74%24.94B | -11.40%25.76B | -10.33%25.83B | -11.37%27.85B | -11.03%28.25B | -9.30%29.07B | -8.61%28.81B | 1.76%31.42B | 3.25%31.76B |
| Non Current assets | ||||||||||
| Other equity investment | -24.75%122.69M | -20.07%140.34M | -20.42%140.34M | -20.42%140.34M | -15.86%163.05M | -9.40%175.57M | -8.99%176.36M | -8.99%176.36M | -8.62%193.79M | -8.62%193.79M |
| Investment real estate | -2.20%71.17M | -3.25%72.72M | -6.40%72.78M | -5.86%75.06M | -6.12%72.77M | -5.82%75.17M | -5.82%77.75M | -6.04%79.73M | -30.00%77.52M | -29.58%79.81M |
| Long-term equity investment | 4.51%194.93M | 2.06%194.23M | 2.68%193.57M | 2.71%193.57M | -13.97%186.52M | -11.79%190.31M | -12.22%188.51M | -11.29%188.46M | -35.13%216.8M | -38.97%215.74M |
| Long term receivable account | ---- | ---- | ---- | ---- | -88.95%610.8K | -6.25%5.13M | -61.50%5.67M | -74.63%3.71M | -68.59%5.53M | -70.96%5.47M |
| Fixed assets | ---- | -9.72%891.52M | ---- | ---- | ---- | -10.72%987.47M | ---- | -10.08%1.04B | ---- | -3.05%1.11B |
| Constru in process | ---- | 25.88%98.51M | ---- | ---- | ---- | 62.18%78.26M | ---- | 93.64%55.94M | ---- | 27.83%48.25M |
| Intangible assets | -12.58%322.67M | -13.33%323.31M | -11.41%328.39M | -3.56%367.6M | -4.94%369.11M | -5.75%373.03M | -7.56%370.7M | -7.01%381.16M | -7.06%388.3M | -7.31%395.78M |
| Development expenditure | 5.92%108.13M | 9.35%109.31M | 10.04%105.98M | 12.84%102.66M | -13.43%102.09M | -12.18%99.96M | -15.63%96.31M | -16.20%90.98M | 6.79%117.92M | 4.55%113.83M |
| Goodwill | -55.78%378.7M | -55.78%378.7M | -56.13%378.7M | -56.13%378.7M | -50.93%856.49M | -50.93%856.49M | -50.54%863.29M | -50.54%863.29M | -24.73%1.75B | -25.04%1.75B |
| Long deferred expense | -6.20%24.49M | -14.85%25.01M | -11.41%27.51M | -9.57%29.53M | -21.70%26.11M | -20.63%29.37M | -23.61%31.06M | -19.61%32.65M | -28.45%33.35M | -18.38%37M |
| Deferred tax assets | 15.87%331.36M | 12.84%332.56M | 8.49%330.75M | 16.71%357.02M | -25.88%285.98M | -24.31%294.71M | -21.35%304.87M | -22.44%305.89M | 7.45%385.85M | 14.24%389.35M |
| Usufruct assets | -37.61%132.67M | -32.18%131.99M | -31.60%139.49M | -18.92%147.98M | 42.75%212.65M | 21.47%194.63M | 16.25%203.92M | -4.70%182.51M | -27.73%148.97M | -29.86%160.23M |
| Other non current assets | -72.46%33.16M | -76.34%34.71M | -19.80%134.44M | 39.45%134.95M | -21.13%120.4M | -12.83%146.68M | 20.91%167.63M | -35.69%96.78M | -70.67%152.65M | -67.50%168.26M |
| Total non current assets | -22.25%2.7B | -22.07%2.73B | -20.70%2.85B | -15.21%2.96B | -24.38%3.47B | -24.73%3.51B | -23.23%3.59B | -26.10%3.5B | -21.77%4.59B | -20.67%4.66B |
| Total assets | -12.91%27.28B | -12.88%27.67B | -12.42%28.6B | -10.85%28.8B | -13.03%31.32B | -12.78%31.76B | -11.07%32.66B | -10.89%32.3B | -2.00%36.01B | -0.59%36.41B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -5.23%9.92B | -6.44%9.77B | -7.88%9.93B | -7.47%10.02B | -11.02%10.47B | -12.09%10.44B | -10.02%10.78B | -5.07%10.83B | 5.65%11.77B | 7.68%11.88B |
| Transactional financial liabilities | -17.63%66.97M | -17.07%72.71M | -30.35%72.71M | -40.91%72.71M | -46.39%81.3M | -49.36%87.68M | -52.93%104.4M | -47.77%123.05M | -52.67%151.66M | -54.63%173.16M |
| Notes payable and accounts payable | -14.59%8.35B | -16.01%8.43B | -13.11%9.05B | -8.73%9.1B | 0.50%9.78B | 0.82%10.04B | 2.11%10.41B | -0.85%9.97B | -4.45%9.73B | -0.21%9.96B |
| -Notes payable | -51.59%1.1B | -49.78%1.3B | -33.14%1.86B | -25.86%1.76B | 1.67%2.28B | 28.48%2.59B | 25.60%2.79B | 10.53%2.37B | -3.45%2.24B | -13.88%2.01B |
| -Accounts payable | -3.36%7.25B | -4.30%7.13B | -5.79%7.18B | -3.39%7.34B | 0.15%7.5B | -6.18%7.45B | -4.43%7.62B | -3.94%7.6B | -4.75%7.49B | 3.97%7.94B |
| Contract liabilities | -13.50%378.94M | -16.45%389.15M | -33.95%364.63M | -37.55%363.61M | -19.22%438.08M | -25.86%465.76M | -14.24%552.06M | -17.77%582.27M | 10.27%542.33M | 42.82%628.19M |
| Advance receipts | -29.84%1.36M | -25.86%1.71M | -39.65%1.5M | -10.02%1.27M | -49.48%1.94M | -50.80%2.31M | -23.52%2.48M | -44.91%1.41M | --3.84M | --4.69M |
| Salaries payable | 13.28%75.22M | 14.89%77.76M | 7.24%80.59M | 17.33%124.12M | -13.99%66.4M | -18.49%67.68M | -16.56%75.15M | -9.95%105.78M | 0.60%77.2M | 16.77%83.03M |
| Taxs payable | -26.21%105.84M | -27.27%102.42M | -26.51%115.7M | -25.72%116.14M | -29.17%143.45M | -32.23%140.83M | -40.41%157.43M | -40.42%156.36M | -8.84%202.53M | -4.44%207.8M |
| Other payable (including interest and dividends) | -11.27%4.51B | -4.66%4.97B | -4.61%5.03B | -2.68%5.1B | -19.46%5.08B | -16.84%5.21B | -14.69%5.27B | -16.73%5.24B | 6.54%6.31B | 3.44%6.26B |
| -Dividend payable | -31.46%89.37M | -22.95%91.55M | 15.85%115.53M | 35.97%143.51M | 19.71%130.4M | 0.01%118.82M | -4.43%99.73M | -4.09%105.55M | -7.11%108.93M | 1.31%118.8M |
| -Other payable | ---- | -4.23%4.87B | ---- | ---- | ---- | -17.17%5.09B | ---- | -16.95%5.13B | ---- | 3.48%6.14B |
| Non current liabilities due within one year | -36.57%134.5M | -44.20%126.41M | -55.34%115.94M | -10.04%221.1M | -8.51%212.06M | -2.91%226.53M | 21.52%259.59M | 19.75%245.79M | 30.94%231.77M | 15.26%233.32M |
| Other current liabilities | -6.32%387.09M | 10.49%451.58M | 11.39%450.01M | -2.80%457.99M | -3.93%413.21M | -0.40%408.71M | 7.67%404M | 16.50%471.16M | 75.12%430.11M | 65.28%410.34M |
| Total current liabilities | -10.32%23.94B | -9.97%24.39B | -10.03%25.2B | -7.75%25.58B | -9.37%26.69B | -9.21%27.09B | -7.13%28.01B | -6.62%27.73B | 2.33%29.45B | 4.24%29.84B |
| Current liabilities | ||||||||||
| Long term loan | 42.76%384.67M | 22.88%319.88M | 70.07%356.1M | 14.66%229.8M | -0.55%269.45M | -1.40%260.31M | -19.32%209.39M | -30.22%200.42M | -11.55%270.94M | -14.04%264.02M |
| Long term account payable | ---- | -11.17%4.93M | ---- | ---- | ---- | -25.26%5.55M | ---- | -66.18%2.43M | ---- | -40.33%7.42M |
| Long term salaries pay | -24.32%181.97K | -24.32%181.97K | -24.32%181.97K | -24.32%181.97K | -21.29%240.43K | -21.29%240.43K | -21.29%240.43K | -21.29%240.43K | -22.08%305.45K | -22.08%305.45K |
| Estimate liabilities | --499.53K | --499.53K | --499.53K | --19.54M | ---- | ---- | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | -0.97%12.41M | -7.95%11.85M | -21.05%10.27M | -6.59%12.28M | -6.06%12.53M | -5.90%12.87M | -1.70%13.01M | -12.07%13.15M | -9.78%13.34M | -14.92%13.68M |
| Long term deferred income | -65.31%4.85M | -65.50%4.88M | -63.79%8.2M | -55.44%10.19M | -41.59%13.98M | -41.56%14.14M | 2.81%22.64M | -13.65%22.87M | 1.76%23.94M | -18.16%24.2M |
| Lease liabilities | -35.42%87.88M | -32.16%85.1M | -35.91%93.52M | -16.61%99.89M | 117.91%136.08M | 40.83%125.45M | 53.75%145.91M | 6.62%119.78M | -44.11%62.45M | -31.47%89.08M |
| Total non current liabilities | 13.17%494.44M | 2.09%427.32M | 20.03%471.32M | 4.60%375.39M | 16.72%436.89M | 4.98%418.56M | -1.48%392.67M | -19.98%358.88M | -33.89%374.31M | -33.06%398.7M |
| Total liabilities | -9.94%24.43B | -9.78%24.82B | -9.62%25.67B | -7.59%25.95B | -9.04%27.13B | -9.03%27.51B | -7.05%28.41B | -6.82%28.09B | 1.63%29.83B | 3.48%30.24B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%2.63B | -4.35%2.63B | -4.35%2.63B | -4.35%2.63B | -4.35%2.63B | 0.00%2.75B | 0.00%2.75B | 0.00%2.75B | 0.00%2.75B | 0.00%2.75B |
| Capital reserve funds | 1.11%2.1B | -6.39%2.1B | -6.52%2.1B | -6.52%2.1B | -6.35%2.07B | 1.23%2.24B | 1.26%2.24B | 0.82%2.24B | -4.05%2.22B | -4.08%2.22B |
| Surplus reserve funds | 0.00%52.14M | 0.00%52.14M | 0.00%52.14M | 0.00%52.14M | 0.00%52.14M | 0.00%52.14M | 0.00%52.14M | 0.00%52.14M | 0.00%52.14M | 0.00%52.14M |
| Retained profit | -72.07%-2.9B | -71.63%-2.89B | -71.82%-2.9B | -68.96%-2.92B | -3,699.53%-1.68B | -3,764.16%-1.69B | -5,239.44%-1.69B | -4,155.04%-1.73B | -95.81%46.79M | -95.82%45.99M |
| Less:Treasury stock | ---- | ---- | ---- | ---- | ---- | 0.00%275.12M | 0.00%275.12M | 0.00%275.12M | 0.00%275.12M | 0.00%275.12M |
| Other composite income | -60.41%-60.3M | -60.41%-60.3M | -63.85%-60.3M | -63.85%-60.3M | -94.05%-37.59M | -94.05%-37.59M | -89.97%-36.8M | -89.97%-36.8M | -76.91%-19.37M | -76.91%-19.37M |
| Shareholders equity without minority interests | -39.97%1.82B | -39.96%1.83B | -40.28%1.82B | -40.22%1.8B | -36.36%3.04B | -36.11%3.05B | -35.96%3.05B | -36.00%3B | -19.73%4.77B | -19.51%4.77B |
| Minority interests | -11.42%1.02B | -15.11%1.02B | -8.23%1.11B | -13.67%1.05B | -18.44%1.15B | -14.43%1.2B | -14.19%1.21B | -14.47%1.21B | -2.67%1.42B | -5.20%1.4B |
| Total shareholder equity | -32.11%2.85B | -32.93%2.85B | -31.16%2.93B | -32.57%2.84B | -32.26%4.19B | -31.18%4.25B | -30.98%4.26B | -31.00%4.22B | -16.38%6.19B | -16.65%6.17B |
| Total liabilityies and equity | -12.91%27.28B | -12.88%27.67B | -12.42%28.6B | -10.85%28.8B | -13.03%31.32B | -12.78%31.76B | -11.07%32.66B | -10.89%32.3B | -2.00%36.01B | -0.59%36.41B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.